MLANA and neoplasm: The percentage of SHH-positive cells in Melan-A-positive tumor cells was significantly decreased in the GANT61-treated group (LI: 45 ± 5.08%) compared to the control group (LI: 65 ± 2.63%) (Figure 3C, p < 0.05).